• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

47.99 -0.45 (-0.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
36 37 Next >
News headline image
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom ↗
June 24, 2024
These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years. 
Via InvestorPlace
News headline image
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom ↗
June 12, 2024
With so many young people eager to get out of the corporate rat race, these FIRE stocks can accelerate your path and stay free. 
Via InvestorPlace
News headline image
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought ↗
June 09, 2024
These companies could generate explosive growth over time. 
Via The Motley Fool
News headline image
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? ↗
June 04, 2024
In keeping with Cathie Wood's style, these picks are riskier than average. 
Via The Motley Fool
News headline image
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You? ↗
May 31, 2024
Teladoc's share performance has reflected its earnings struggles... 
Via The Motley Fool
News headline image
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow ↗
May 26, 2024
There are a handful of different factors that could buoy its stock. 
Via The Motley Fool
News headline image
Is CRISPR Therapeutics a Millionaire Maker? ↗
May 22, 2024
The stars are aligning for it to be a leader for years to come. 
Via The Motley Fool
News headline image
Is CRISPR Therapeutics Stock a Buy? ↗
May 17, 2024
The gene-editing therapy specialist is rising in prominence. 
Via The Motley Fool
News headline image
7 Stocks You Haven’t Heard of (That EVERYONE Should Own) ↗
May 29, 2024
These under-the-radar must-own stocks across various sectors are using powerful megatrends and posting solid financial results. 
Via InvestorPlace
News headline image
7 Biotech Stocks to Put on Your Breakthrough Radar ↗
May 27, 2024
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance. 
Via InvestorPlace
News headline image
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now ↗
May 23, 2024
With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy. 
Via InvestorPlace
News headline image
7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition ↗
May 22, 2024
With a modest $1,000 investment, these stocks offer the potential for market-beating gains through solid fundamentals and growth prospects. 
Via InvestorPlace
News headline image
Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗
May 22, 2024
These biotech stocks have just launched their first products. 
Via The Motley Fool
News headline image
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗
May 17, 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. 
Via InvestorPlace
News headline image
7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024 ↗
May 16, 2024
Here are seven stocks to buy and hold that are poised for long-term growth over the next 20 years and can future-proof your portfolio. 
Via InvestorPlace
News headline image
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. ↗
May 15, 2024
How much would you pay for a stock that might earn $25 a year in six years? 
Via The Motley Fool
News headline image
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential ↗
May 14, 2024
These healthcare stocks offer completely different approaches to long-term investment gains. 
Via The Motley Fool
News headline image
The 3 Best Cathie Wood Stocks to Buy in May 2024 ↗
May 13, 2024
Cathie Wood takes a very risky approach to investing, but she has plenty of great picks. Here are some of the best Cathie Wood stocks to buy. 
Via InvestorPlace
News headline image
The 3 Most Undervalued Biotech Stocks to Buy in May 2024 ↗
May 11, 2024
Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns. 
Via InvestorPlace
News headline image
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗
May 10, 2024
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. 
Via InvestorPlace
News headline image
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine ↗
May 09, 2024
These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot. 
Via InvestorPlace
News headline image
CRSP Stock Earnings: CRISPR Therapeutics Misses EPS, Misses Revenue for Q1 2024 ↗
May 08, 2024
CRSP stock results show that CRISPR Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire ↗
May 04, 2024
Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments. 
Via InvestorPlace
News headline image
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar ↗
May 03, 2024
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines. 
Via InvestorPlace
News headline image
3 Growth Stocks You’ll Kick Yourself for Not Buying Today ↗
May 03, 2024
Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns. 
Via InvestorPlace
News headline image
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond ↗
May 02, 2024
It pays to develop novel medicines for life-threatening illnesses. 
Via The Motley Fool
News headline image
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗
May 02, 2024
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. 
Via InvestorPlace
News headline image
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge ↗
May 01, 2024
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount. 
Via InvestorPlace
News headline image
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
April 24, 2024
Good news could be just around the corner for two drugmakers not named Novo Nordisk. 
Via The Motley Fool
News headline image
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? ↗
April 23, 2024
Vertex is broadening its portfolio. 
Via The Motley Fool
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap